Cited by 249Escherichia coli research studiesUrinary Tract Infections ManagementBacterial Infections and Vaccines

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Extraintestinal Pathogenic Escherichia coli , a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

Open access

Poolman, Jan T., Wacker, Michael·2016·Journal of Infectious Diseases

Open this paper in CoChat — free account

Abstract

Extraintestinal pathogenic Escherichia coli (ExPEC) is the most common gram-negative bacterial pathogen in humans. ExPEC causes the vast majority of urinary tract infections (UTIs), is a leading cause of adult bacteremia, and is the second most common cause of neonatal meningitis. Increasing multidrug resistance among ExPEC strains constitutes a major obstacle to treatment and is implicated in increasing numbers of hospitalizations and deaths and increasing healthcare costs associated with ExPEC infections. An effective vaccine against ExPEC infection is urgently needed. The O antigen, a component of the surface lipopolysaccharide, has been identified as a promising vaccine target. With the availability of a novel bioconjugation technology it is expected that multivalent O antigen conjugate vaccines can be produced at industrial scale. Clinical proof of concept of a 4-valent O antigen conjugate vaccine is ongoing. An ExPEC vaccine effective against strains that are associated with major diseases and resistant to multiple drugs could be routinely delivered to individuals at risk of developing severe E. coli infection, such as elderly people, individuals undergoing abdominal surgery and prostatic biopsy procedures, and persons at risk of recurrent and/or complicated UTI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/infdis/jiv429

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figure 1. Distribution of pathogens among isolates from 80 089 hospital admissions in 19 US hospitals between 2007 and 2010 [10]. Abbreviations: A. baumannii, Acinetobacter baumannii; E. coli, Escherichia coli; E. faecalis, Enterococcus faecalis; E. faecium, Enterococcus faecium; K. pneumoniae, Klebsiella pneumoniae; P. aeruginosa, Pseudomonas aeruginosa; S. aureus, Staphylococcus aureus.CC BY-NC-ND · PubMed Central

Figure 2. A, Incidence of Escherichia coli bacteremia, by age, in Auckland, New Zealand, between 2005 and 2011. The figure is reproduced from the article by Williamson et al [20]. B, rising numbers of E. coli bacteremia isolates reported to the European Antimicrobial Resistance Surveillance System between 2002 and 2008. Data are from the article by De Kraker et al [16]. Abbreviations: E. coli, Escherichia coli; S. aureus, Staphylococcus aureus; S. pneumoniae, Streptococcus pneumoniae.CC BY-NC-ND · PubMed Central

Figure 3. Escherichia coli O serotypes causing extraintestinal infections. Data are from the article by Orskov et al [41]. Abbreviation: UTIs, urinary tract infections.CC BY-NC-ND · PubMed Central

Figure 4. Process of in vivo bioconjugation, using recombinant Escherichia coli. Campylobacter oligosaccharyltransferase (PglB) transfers selected O polysaccharides (devoid of lipids) to the Pseudomonas aeruginosa exoprotein A (EPA) protein carrier present in the periplasm. Abbreviation: SEC, secretory pathway.CC BY-NC-ND · PubMed Central

Figure 5. Challenges to extraintestinal pathogenic Escherichia coli vaccine development. Individual challenges to vaccine development need to be surmounted to achieve successful technical development, appropriate strain selection, and demonstration of efficacy in the target population. Abbreviation: UTI, urinary tract infection.CC BY-NC-ND · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A. K., Patel, J. B., Srinivasan, A., Kallen, A. J., Limbago, B. M., Fridkin, S. K., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,593
Urinary Tract Infection Syndromes
Foxman, B. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.09.003 · Cited by 1,336
Biosynthesis and Assembly of Capsular Polysaccharides in Escherichia coli
Whitfield, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142545 · Cited by 993
Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem
Russo, T. A., & Johnson, J. R. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00049-2 · Cited by 801
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685
Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 511
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli
Feldman, M. F., Wacker, M., Hernandez, M., Hitchen, P. G., Marolda, C. L., Kowarik, M., Morris, H. R., Dell, A., Valvano, M. A., & Aebi, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500044102 · Cited by 442
Self-citation
The structures of Escherichia coli O-polysaccharide antigens
Stenutz, R., Weintraub, A., & Widmalm, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00016.x · Cited by 410

Show all 48 references

Research works printed but not linked: 4

Vahlne, 1945, Serological typing of the colon bacteria, with special reference to the occurrence of B. coli in man under normal and pathological conditions, particularly in appendicitis, Acta Path Microbiol Scand, 62, 1
Sjostedt, 1946, Pathogenicity of certain serological types of B. coli: their mouse toxicity, hemolytic power, capacity for skin necrosis and resistance to phagocytosis and bactericidal faculties of human blood, Acta Path Microbiol Scand, 63, 1
Elixhauser A , Friedman B , Stranges E . Septicemia in U.S. Hospitals, 2009. Statistical brief 122. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research, 2006. http://www.ncbi.nlm.nih.gov/books/NBK65391/ . Accessed 27 January 2015.
Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. The Review on Antimicrobial Resistance Chaired by Jim O'Neill, 2014. http://www.his.org.uk/files/4514/1829/6668/AMR_Review_Paper_-_Tackling_a_crisis_for_the_health_and_wealth_of_nations_1.pdf . Accessed 26 December 2014.

Sorted by citations

UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies
Terlizzi, M., Gribaudo, G., & Maffei, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01566 · Cited by 627
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Alvarez, M. J. R., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 628
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry
Liu, C. G., Green, S. I., Min, L., Clark, J. R., Salazar, K. C., Terwilliger, A. L., Kaplan, H. B., Trautner, B. W., Ramig, R. F., & Maresso, A. W. (2020) · mBio · doi:10.1128/mbio.01462-20 · Cited by 411
Genomic surveillance for antimicrobial resistance — a One Health perspective
Djordjevic, S. P., Jarocki, V. M., Seemann, T., Cummins, M. L., Watt, A. E., Drigo, B., Wyrsch, E. R., Reid, C. J., Donner, E., & Howden, B. P. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00649-y · Cited by 388
The role of vaccines in preventing bacterial antimicrobial resistance
Jansen, K. U., Knirsch, C. A., & Anderson, A. S. (2018) · Nature Medicine · doi:10.1038/nm.4465 · Cited by 355
Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review
Bonten, M. J. M., Johnson, J. R., van den Biggelaar, A. H. J., Georgalis, L., Geurtsen, J., de Palacios, P. I., Gravenstein, S., Verstraeten, T., Hermans, P. W. M., & POOLMAN, J. T. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa210 · Cited by 350
Self-citation
Global etiology of bacterial meningitis: A systematic review and meta-analysis.
Oordt-Speets, A. M., Bolijn, R., van Hoorn, R. C., Bhavsar, A., & Kyaw, M. H. (2018) · PloS One · doi:10.1371/journal.pone.0198772 · Cited by 288
Genomics and pathotypes of the many faces of Escherichia coli
Geurtsen, J., de Been, M., Weerdenburg, E., Zomer, A., McNally, A., & POOLMAN, J. T. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac031 · Cited by 270
Self-citation
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
Lipsitch, M., & Siber, G. R. (2016) · mBio · doi:10.1128/mbio.00428-16 · Cited by 236
One Health Genomic Surveillance of Escherichia coli Demonstrates Distinct Lineages and Mobile Genetic Elements in Isolates from Humans versus Livestock
Ludden, C., Raven, K. E., Jamrozy, D. M., Gouliouris, T., Blane, B., Coll, F., de Goffau, M. C., Naydenova, P., Horner, C., Hernandez-Garcia, J., et al. (2019) · mBio · doi:10.1128/mbio.02693-18 · Cited by 232
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Huttner, A. C., Hatz, C., van den Dobbelsteen, G., Abbanat, D., Hornacek, A., Frölich, R., Dreyer, A. M., MARTIN, P. A., Davies, T. A., Fae, K. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30108-1 · Cited by 208
Self-citation
Escherichia coliandStaphylococcus aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations
POOLMAN, J. T., & Anderson, A. S. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1488590 · Cited by 169
Self-citation
The role of vaccines in fighting antimicrobial resistance (AMR)
Jansen, K. U., & Anderson, A. S. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1476814 · Cited by 158
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
Laxminarayan, R., Impalli, I., Rangarajan, R., Cohn, J., Ramjeet, K., Trainor, B. W., Strathdee, S., Sumpradit, N., Berman, D., Wertheim, H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00878-x · Cited by 111
Escherichia coli β-Lactamases: What Really Matters
Bajaj, P., Singh, N. S., & Virdi, J. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00417 · Cited by 107
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
Khalid, K., & Poh, C. L. (2023) · Vaccines · doi:10.3390/vaccines11071264 · Cited by 106
An Escherichia coli ST131 pangenome atlas reveals population structure and evolution across 4,071 isolates
Decano, A. G., & Downing, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-54004-5 · Cited by 95
Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence
Vacante, M., Ciuni, R., Basile, F., & Biondi, A. (2020) · Biomedicines · doi:10.3390/biomedicines8110489 · Cited by 98
Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – Potential and limitations
Bröker, M., Berti, F., Schneider, J., & Vojtek, I. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.078 · Cited by 93
Porcine commensal Escherichia coli: a reservoir for class 1 integrons associated with IS26
Reid, C. J., Wyrsch, E. R., Chowdhury, P. R., Zingali, T., Liu, M., Darling, A., Chapman, T., & Djordjevic, S. (2017) · bioRxiv · doi:10.1099/mgen.0.000143 · Cited by 87
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial
Frenck, R. W., Ervin, J. E., Chu, L., Abbanat, D., Spiessens, B., Go, O. T., Haazen, W., van den Dobbelsteen, G., POOLMAN, J. T., Thoelen, S., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30803-x · Cited by 91
Self-citation
Whole genome sequence analysis of Australian avian pathogenic Escherichia coli that carry the class 1 integrase gene
Cummins, M. L., Reid, C. J., Chowdhury, P. R., Bushell, R. N., Esbert, N., Tivendale, K. A., Noormohammadi, A. H., Islam, S., Marenda, M. S., Browning, G. F., et al. (2019) · Microbial Genomics · doi:10.1099/mgen.0.000250 · Cited by 76
Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract
Green, S. I., Liu, C. G., Yu, X. Q., Gibson, S., Salmen, W., Rajan, A., Carter, H. E., Clark, J. R., Song, X., Ramig, R. F., et al. (2021) · mBio · doi:10.1128/mbio.03474-20 · Cited by 73
The impact of human vaccines on bacterial antimicrobial resistance. A review
Jansen, K. U., Gruber, W. C., Simon, R., Wassil, J., & Anderson, A. S. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01274-z · Cited by 79
Simultaneous detection of Escherichia coli O157:H7, Staphylococcus aureus and Salmonella by multiplex PCR in milk
Wei, C., Zhong, J., Hu, T., & Zhao, X. (2018) · 3 Biotech · doi:10.1007/s13205-018-1086-5 · Cited by 63
Antimicrobial Resistance Profile and ExPEC Virulence Potential in Commensal Escherichia coli of Multiple Sources
Massella, E., Giacometti, F., Bonilauri, P., Reid, C. J., Djordjevic, S. P., Merialdi, G., Bacci, C., Fiorentini, L., Massi, P., Bardasi, L., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10040351 · Cited by 64
Molecular Characteristics of ST1193 Clone among Phylogenetic Group B2 Non-ST131 Fluoroquinolone-Resistant Escherichia coli
Wu, J., Lan, F., Lu, Y., He, Q., & Li, B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02294 · Cited by 56
Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis
Yang, W. H., Heithoff, D. M., Aziz, P. V., Haslund-Gourley, B. S., Westman, J. S., Narisawa, S., Pinkerton, A. B., Millán, J. L., Nizet, V., Mahan, M. J., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.09.011 · Cited by 56
Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
van den Dobbelsteen, G. P. J. M., Fae, K. C., Serroyen, J., van den Nieuwenhof, I. M., Braun, M., Haeuptle, M. A., Sirena, D., Schneider, J., Alaimo, C., Lipowsky, G., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.067 · Cited by 54
Self-citation
Current and emerging strategies to curb antibiotic-resistant urinary tract infections
Simoni, A., Schwartz, L., Junquera, G. Y., Ching, C. B., & Spencer, J. (2024) · Nature reviews. Urology · doi:10.1038/s41585-024-00877-9 · Cited by 60
Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones
Ludden, C., Decano, A. G., Jamrozy, D. M., Pickard, D., Morris, D., Parkhill, J., Peacock, S. J., Cormican, M., & Downing, T. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000352 · Cited by 51
Multidrug Resistant Uropathogenic Escherichia coli ST405 With a Novel, Composite IS26 Transposon in a Unique Chromosomal Location
Chowdhury, P. R., McKinnon, J., Liu, M., & Djordjevic, S. P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03212 · Cited by 52
Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections
POOLMAN, J. T. (2020) · npj Vaccines · doi:10.1038/s41541-020-00232-0 · Cited by 53
Self-citation
Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals
Nešporová, K., Wyrsch, E. R., Valček, A., Bitar, I., Chaw, K., Harris, P. N. A., Hrabák, J., Literák, I., Djordjevic, S. P., & Dolejská, M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01118-20 · Cited by 54
Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies
Weerdenburg, E., Davies, T., Morrow, B., Zomer, A. L., Hermans, P., Go, O., Spiessens, B., van den Hoven, T., van Geet, G., Aitabi, M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac421 · Cited by 49
Self-citation
The Population Genomics of Increased Virulence and Antibiotic Resistance in Human Commensal Escherichia coli over 30 Years in France
Marin, J., Clermont, O., Royer, G., Mercier-Darty, M., Decousser, J., Tenaillon, O., Denamur, É., & Blanquart, F. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.00664-22 · Cited by 48
Genomic Microbial Epidemiology Is Needed to Comprehend the Global Problem of Antibiotic Resistance and to Improve Pathogen Diagnosis
Wyrsch, E. R., Chowdhury, P. R., Chapman, T., Charles, I., Hammond, J., & Djordjevic, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00843 · Cited by 45
Genomic and Temporal Trends in Canine ExPEC Reflect Those of Human ExPEC
Elankumaran, P., Cummins, M. L., Browning, G. F., Marenda, M. S., Reid, C. J., & Djordjevic, S. P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01291-22 · Cited by 48
The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli
Huttner, A. C., & Gambillara, V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.05.009 · Cited by 46
High Genomic Diversity and Heterogenous Origins of Pathogenic and Antibiotic-Resistant Escherichia coli in Household Settings Represent a Challenge to Reducing Transmission in Low-Income Settings
Montealegre, M. C., Talavera-Rodríguez, A., Roy, S., Hossain, M. I., Islam, M. A., Lanza, V. F., & Julian, T. R. (2020) · mSphere · doi:10.1128/msphere.00704-19 · Cited by 45
Australian porcine clonal complex 10 (CC10) Escherichia coli belong to multiple sublineages of a highly diverse global CC10 phylogeny
Reid, C. J., DeMaere, M., & Djordjevic, S. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000225 · Cited by 39
Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa
Antonelli, G., Cappelli, L., Cinelli, P., Cuffaro, R., Manca, B., Nicchi, S., Tondi, S., Vezzani, G., Viviani, V., Delany, I., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094943 · Cited by 45
Epidemiology of extended-spectrum β-lactamase–producing Enterobacterales in five US sites participating in the Emerging Infections Program, 2017
Duffy, N., Karlsson, M., Reses, H. E., Campbell, D., Daniels, J., Stanton, R. A., Janelle, S. J., Schutz, K., Bamberg, W., Rebolledo, P. A., et al. (2022) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.496 · Cited by 39
The relation of phylogroups, serogroups, virulence factors and resistance pattern of Escherichia coli isolated from children with septicemia
Nojoomi, F., & Ghasemian, A. (2019) · New Microbes and New Infections · doi:10.1016/j.nmni.2019.100517 · Cited by 39
Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges
Qiu, L., Chirman, D. M., Clark, J. R., Xing, Y., Santos, H. H., Vaughan, E. E., & Maresso, A. W. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2359691 · Cited by 41
Co-delivery of ampicillin and β-lactamase inhibitor by selenium nanocomposite to achieve synergistic anti-infective efficiency through overcoming multidrug resistance
Wang, Z., Zhang, P., Ding, X., Wang, J., Sun, Y., Yin, C., Wang, W., Fan, C., & Sun, D. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.128908 · Cited by 38
Vaccines Against Escherichia coli
Nesta, B., & Pizza, M. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_111 · Cited by 36
Neonate Bloodstream Infections in Organization for Economic Cooperation and Development Countries: An Update on Epidemiology and Prevention
Wójkowska‐Mach, J., Chmielarczyk, A., Strus, M., Lauterbach, R., & Heczko, P. B. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101750 · Cited by 36
Snapshot Study of Whole Genome Sequences of Escherichia coli from Healthy Companion Animals, Livestock, Wildlife, Humans and Food in Italy
Massella, E., Reid, C. J., Cummins, M., Anantanawat, K., Zingali, T., Serraino, A., Piva, S., Giacometti, F., & Djordjevic, S. (2020) · Antibiotics · doi:10.3390/antibiotics9110782 · Cited by 29
Complete Assembly of Escherichia coli Sequence Type 131 Genomes Using Long Reads Demonstrates Antibiotic Resistance Gene Variation within Diverse Plasmid and Chromosomal Contexts
Decano, A. G., Ludden, C., Feltwell, T., Judge, K., Parkhill, J., & Downing, T. (2019) · mSphere · doi:10.1128/msphere.00130-19 · Cited by 39
Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections
Li, D., Reid, C. J., Kudinha, T., Jarocki, V. M., & Djordjevic, S. P. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000475 · Cited by 35
Epidemiology, Clinical Features, and Antimicrobial Resistance of InvasiveEscherichia ColiDisease in Patients Admitted in Tertiary Care Hospitals
Doua, J., Geurtsen, J., Rodríguez‐Baño, J., Cornely, O. A., Go, O. T., Grange, A. G., Kirby, A., Hermans, P. W. M., Gori, A., Zuccaro, V., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad026 · Cited by 38
Self-citation
Proanthocyanidin-chitosan composite nanoparticles prevent bacterial invasion and colonization of gut epithelial cells by extra-intestinal pathogenic Escherichia coli
Alfaro‐Viquez, E., Alvarado, D. E., Madrigal‐Carballo, S., Krueger, C. G., & Reed, J. D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.170 · Cited by 34
Comparative Pathogenomics ofEscherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis
Clark, J. R., & Maresso, A. W. (2021) · Infection and Immunity · doi:10.1128/iai.00115-21 · Cited by 33
The role of the bacterial protease Prc in the uropathogenesis of extraintestinal pathogenic Escherichia coli
Huang, W.-C., Lin, C., Hashimoto, M., Wu, J.-J., Wang, M.-C., Lin, W., Chen, C., & Teng, C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0605-y · Cited by 33
Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections
Lipworth, S., Vihta, K.-D., Chau, K., Kavanagh, J., Davies, T. J., George, S. A., Barker, L., Vaughan, A., Andersson, M. I., Jeffery, K. J., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab006 · Cited by 33
The Pheno- and Genotypic Characterization of Porcine Escherichia coli Isolates
Bernreiter-Hofer, T., Schwarz, L., Müller, E., Cabal-Rosel, A., Korus, M., Mišić, D., Frankenfeld, K., Abraham, K., Grünzweil, O., Weiss, A., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9081676 · Cited by 27
Trends in ExPEC serogroups in the UK and their significance
Ciesielczuk, H., Jenkins, C., Chattaway, M. A., Doumith, M., Hope, R., Woodford, N., & Wareham, D. W. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2707-8 · Cited by 33
First Detection of Carbapenem-Resistant Escherichia fergusonii Strains Harbouring Beta-Lactamase Genes from Clinical Samples
Adesina, T. D., Nwinyi, O. C., De, N., Akinnola, O. O., & Omonigbehin, E. A. (2019) · Pathogens · doi:10.3390/pathogens8040164 · Cited by 33
NMDA receptor modulation of glutamate release in activated neutrophils
del Arroyo, A. G., Hadjihambi, A., Sanchez, J., Turovsky, E. A., Kasymov, V., Cain, D. J., Nightingale, T. D., Lambden, S., Grant, S. G. N., Gourine, A. V., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.004 · Cited by 31
Dominance of Escherichia coli sequence types ST73, ST95, ST127 and ST131 in Australian urine isolates: a genomic analysis of antimicrobial resistance and virulence linked to F plasmids
Li, D., Elankumaran, P., Kudinha, T., Kidsley, A. K., Trott, D. J., Jarocki, V. M., & Djordjevic, S. P. (2023) · Microbial Genomics · doi:10.1099/mgen.0.001068 · Cited by 34
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study
Fierro, C. A., Sarnecki, M., Doua, J., Spiessens, B., Go, O. T., Davies, T. A., van den Dobbelsteen, G., POOLMAN, J. T., Abbanat, D., & Haazen, W. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad417 · Cited by 31
Self-citation
Genetic analysis of invasive Escherichia coli in Scotland reveals determinants of healthcare-associated versus community-acquired infections
Goswami, C., Fox, S. P., Holden, M. T. G., Connor, M., Leanord, A., & Evans, T. J. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000190 · Cited by 35
Phylogenomic analysis of a global collection of Escherichia coli ST38: evidence of interspecies and environmental transmission?
Chowdhury, P. R., Hastak, P., DeMaere, M. Z., Wyrsch, E. R., Li, D., Elankumaran, P., Dolejská, M., Browning, G. F., Marenda, M. S., Gottlieb, T., et al. (2023) · mSystems · doi:10.1128/msystems.01236-22 · Cited by 29
Secreted proteases: A new insight in the pathogenesis of extraintestinal pathogenic Escherichia coli
Tapader, R., Basu, S., & Pal, A. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.03.002 · Cited by 29
Extraintestinal pathogenic Escherichia coli (ExPEC) reservoirs, and antibiotics resistance trends: a one-health surveillance for risk analysis from “ farm-to-fork ”
Meena, P. R., Priyanka, P., & Singh, A. P. (2022) · Letters in Applied Microbiology · doi:10.1093/lambio/ovac016 · Cited by 29
The development and characterization of an E. coli O25B bioconjugate vaccine
Kowarik, M., Wetter, M., Haeuptle, M., Braun, M., Steffen, M., Kemmler, S., Ravenscroft, N., Benedetto, G. D., Zuppiger, M., Sirena, D., et al. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-09985-9 · Cited by 23
Self-citation
Therapies in early development for the treatment of urinary tract inflammation
Zacchè, M. M., & Giarenis, I. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1161024 · Cited by 27
Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants
Inoue, M., Ogawa, T., Tamura, H., Hagiwara, Y., Saito, Y., Abbanat, D., van den Dobbelsteen, G., Hermans, P. W. M., Thoelen, S., POOLMAN, J. T., et al. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1474316 · Cited by 27
Self-citation
Causes of death in neotropical primates in Rio Grande do Sul State, Southern Brazil
Ehlers, L. P., Slaviero, M., Bianchi, M. V., de Mello, L. S., Lorenzo, C. D., Surita, L. E., Alievi, M. M., Driemeier, D., Pavarini, S. P., & Sonne, L. (2021) · Journal of Medical Primatology · doi:10.1111/jmp.12557 · Cited by 28
Genomic epidemiology of Escherichia coli isolates from a tertiary referral center in Lilongwe, Malawi
Tegha, G., Ciccone, E. J., Krysiak, R. G., Kaphatika, J., Chikaonda, T., Ndhlovu, I., van Duin, D., Hoffman, I., Juliano, J. J., & Wang, J. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000490 · Cited by 25
Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3
Ohno, M., Hasegawa, M., Hayashi, A., Caballero-Flores, G. G., Alteri, C. J., Lawley, T. D., Kamada, N., Núñez, G., & Inohara, N. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008928 · Cited by 25
Coordination of Metabolism and Virulence Factors Expression of Extraintestinal Pathogenic Escherichia coli Purified from Blood Cultures of Patients with Sepsis
Pettersen, V. K., Mosevoll, K. A., Lindemann, P. C., & Wiker, H. G. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060582 · Cited by 25
Virulence, phylogenetic background and antimicrobial resistance in Escherichia coli associated with extraintestinal infections
Čurová, K., Slebodníková, R., Kmetova, M., Hrabovský, V., Maruniak, M., Liptáková, E., & Siegfried, L. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.06.032 · Cited by 25
Emergence of Escherichia coli ST131 Causing Urinary Tract Infection in Western Asia: A Systematic Review and Meta-Analysis
Jafari, A., Falahatkar, S., Delpasand, K., Sabati, H., & Ebrahim‐Saraie, H. S. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0312 · Cited by 22
A Thermosensitive, Phase-Variable Epigenetic Switch: pap Revisited
Zamora, M., Ziegler, C. A., Freddolino, L., & Wolfe, A. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00030-17 · Cited by 20
High efficiency biosynthesis of O-polysaccharide-based vaccines against extraintestinal pathogenic Escherichia coli
Jiang, X., Bai, J., Yuan, J., Zhang, H., Lu, G., Wang, Y., Jiang, L., Liu, B., Wang, L., Huang, D., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117475 · Cited by 22
Extraintestinal Pathogenic Escherichia coli: Beta-Lactam Antibiotic and Heavy Metal Resistance
Longhi, C., Maurizi, L., Conte, A. L., Marazzato, M., Comanducci, A., Nicoletti, M., & Zagaglia, C. (2022) · Antibiotics · doi:10.3390/antibiotics11030328 · Cited by 23
Cytotoxic Escherichia coli strains encoding colibactin colonize laboratory mice
García, A., Mannion, A. J., Feng, Y., Madden, C. M., Bakthavatchalu, V., Shen, Z., Ge, Z., & Fox, J. G. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.07.005 · Cited by 22
One-step, rapid fluorescence sensing of fungal viability based on a bioprobe with aggregation-induced emission characteristics
Ge, X., Gao, M., Situ, B., Feng, W., He, B., He, X., Li, S., Ou, Z., Zhong, Y., Lin, Y., et al. (2020) · Materials Chemistry Frontiers · doi:10.1039/c9qm00732f · Cited by 22
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI
Fierro, C. A., Sarnecki, M., Spiessens, B., Go, O. T., Day, T., Davies, T. A., van den Dobbelsteen, G., POOLMAN, J. T., Abbanat, D., & Haazen, W. (2024) · npj Vaccines · doi:10.1038/s41541-024-00885-1 · Cited by 21
Self-citation
Bacteriophage isolated from non‐target bacteria demonstrates broad host range infectivity against multidrug‐resistant bacteria
Ngiam, L., Schembri, M. A., Weynberg, K. D., & Guo, J. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15714 · Cited by 21
Molecular detection of avian pathogenic Escherichia coli (APEC) in broiler meat from retail meat shop
Ranabhat, G., Subedi, D., Karki, J., Paudel, R., Luitel, H., & Bhattarai, R. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35661 · Cited by 23
Antimicrobial resistance and vaccines in Enterobacteriaceae including extraintestinal pathogenic Escherichia coli and Klebsiella pneumoniae
Cabrera, A., Mason, E. L., Mullins, L. P., & Sadarangani, M. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00100-8 · Cited by 20
Genomic Surveillance for One Health Antimicrobial Resistance: Understanding Human, Animal, and Environmental Reservoirs and Transmission
Djordjevic, S. P., Jarocki, V. M., Morgan, B. S., & Donner, E. (2020) · The handbook of environmental chemistry · doi:10.1007/698_2020_626 · Cited by 20
Next-generation diagnostics of bloodstream infections enabled by rapid whole-genome sequencing of bacterial cells purified from blood cultures
Pilato, V. D., Bonaiuto, C., Morecchiato, F., Antonelli, A., Giani, T., & Rossolini, G. M. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105633 · Cited by 20
Plasmids shape the diverse accessory resistomes of Escherichia coli ST131
Decano, A. G., Tran, N. T. H., Al-Foori, H., Al-Awadi, B., Campbell, L., Ellison, K., Mirabueno, L. P., Nelson, M., Power, S., Smith, J., et al. (2020) · Access Microbiology · doi:10.1099/acmi.0.000179 · Cited by 18
Fabrication and bacterial inhibitory activity of essential oil linalool loaded biocapsules against Escherichia coli
Parasuraman, V., Sharmin, A. M., Anand, M. A. V., Sivakumar, A. S., Surendhiran, D., Sharesh, G., & Kim, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103495 · Cited by 20
Pandemic Bacteremic Escherichia Coli Strains: Evolution and Emergence of Drug-Resistant Pathogens
Yair, Y., & Gophna, U. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_109 · Cited by 19
QAC Resistance Genes in ESBL-Producing E. coli Isolated from Patients with Lower Respiratory Tract Infections in the Central Slovenia Region—A 21-Year Survey
Hrovat, K., Zupančič, J. Č., Seme, K., & Avguštin, J. A. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8050273 · Cited by 18
Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States
Hernandez-Pastor, L., Geurtsen, J., Baugh, B., Khoury, A. C. E., Kalu, N. U., Gauthier‐Loiselle, M., Bungay, R., Cloutier, M., Sarnecki, M., & Saade, E. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08479-3 · Cited by 20
Phenotypic and Genotypic Characterization of Escherichia coli Causing Urinary Tract Infections in Kidney-Transplanted Patients
Basha, J. A., Kiel, M., Görlich, D., Schütte‐Nütgen, K., Witten, A., Pavenstädt, H. J., Kahl, B. C., Dobrindt, U., & Reuter, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070988 · Cited by 18
Carbapenem-resistant Escherichia coli from shrimp and salmon available for purchase by consumers in Canada: a risk profile using the Codex framework
Loest, D., Uhland, F., Young, K. M., Li, X.-Z., Mulvey, M., Reid-Smith, R., Sherk, L. M., & Carson, C. (2022) · Epidemiology and Infection · doi:10.1017/s0950268822001030 · Cited by 17
Fitness effects of bla CTX-M-15-harbouring F2:A1:B− plasmids on their native Escherichia coli ST131 H 30Rx hosts
Palkovičová, J., Sukkar, I., DelaFuente, J., Valček, A., Medvecký, M., Jamborová, I., Bitar, I., Phan, M., Millán, Á. S., & Dolejská, M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac250 · Cited by 17
Glycan and Protein Analysis of Glycoengineered Bacterial E. coli Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry
Nicolardi, S., Danuser, R., Dotz, V., Domínguez‐Vega, E., Kaabi, A. A., Beurret, M., Anish, C., & Wuhrer, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04690 · Cited by 17
Clinical features and microbiological characteristics of hospital- and community-onset Escherichia coli bloodstream infection
Chen, X., Zou, Q., Zhang, W., Wang, R., Yu, F., & Chen, Y. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000904 · Cited by 16
Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice
Naini, A., Bartetzko, M. P., Sanapala, S. R., Broecker, F., Wirtz, V., Lisboa, M. P., Parameswarappa, S. G., Knopp, D., Przygodda, J., Hakelberg, M., et al. (2022) · JACS Au · doi:10.1021/jacsau.2c00401 · Cited by 16
Challenges in development of vaccines directed toward antimicrobial resistant bacterial species
Brazzoli, M., Piccioli, D., & Marchetti, F. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2228669 · Cited by 18
Cytotoxic Escherichia coli strains encoding colibactin isolated from immunocompromised mice with urosepsis and meningitis
Bakthavatchalu, V., Wert, K. J., Feng, Y., Mannion, A. J., Ge, Z., García, A., Scott, K. E., Caron, T. J., Madden, C. M., Jacobsen, J. T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194443 · Cited by 16
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique
Santona, A., Sumbana, J. J., Fiamma, M., Deligios, M., Taviani, E., Simbine, S., Zimba, T. F., Sacarlal, J., Rubino, S., & Paglietti, B. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106649 · Cited by 15

Authors: Poolman, J. T., & Wacker, M.
Affiliations: Janssen (Netherlands) (NL)
Corresponding author: Poolman, Jan T.
ORCID: Poolman, Jan T.
Venue: Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2015-09-02
Volume: 213
Issue: 1
Pages: 6-13
ISSN: 0022-1899 (ISSN-L)
1537-6613
DOI: 10.1093/infdis/jiv429
PMC: PMC4676548
OpenAlex: W2243816940
Cited by: 246
References: 48
Citations by year: 2026: 20 · 2025: 25 · 2024: 31 · 2023: 29 · 2022: 30 · 2021: 21 · 2020: 27 · 2019: 26 · 2018: 15 · 2017: 11 · 2016: 11
FWCI: 1.36
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
Locations: The Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords: extraintestinal pathogenic Escherichia coli, vaccine development, lipopolysaccharide, urinary tract infection, bacteremia, neonatal meningitis, multidrug resistance, bioconjugation, multivalent vaccine, vaccine targets
MeSH terms: Escherichia coli, Escherichia coli Infections, Humans, Urinary Tract Infections, O Antigens, Escherichia coli Vaccines, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Extraintestinal Pathogenic Escherichia coli , a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks